Paper3552006
Treatment of primary pulmonary hypertension intravenous epoprostenol (prostacyclin).
Jones DK and 2 others. Br Heart J, 1987. Cited by 159 papers, by iCite.
Cite this record
ConductScience Library. Treatment of primary pulmonary hypertension intravenous epoprostenol (prostacyclin). Papers, record 3552006. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3552006
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Epoprostenol | Major topic |
| Hypertension, Pulmonary | Major topic |
| Adolescent | |
| Adult | |
| Drug Administration Schedule | |
| Female | |
| Hemodynamics | |
| Humans | |
| Infusions, Intravenous | |
| Male | |
| Oxygen Consumption | |
| Physical Exertion |
Source PubMed
References23
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4682413 | Intrapulmonary veno-occlusive disease. | Am J Cardiol | 1973 | https://conductscience.org/library/papers/4682413 | PubMed |
| 2 | 14051185 | LOSS OF REACTIVITY OF THE PULMONARY VASCULAR BED IN PRIMARY PULMONARY HYPERTENSION. | Am Heart J | 1963 | https://conductscience.org/library/papers/14051185 | PubMed |
| 3 | 441578 | The measurement of metabolic gas exchange and minute volume by mass spectrometry alone. | Respir Physiol | 1979 | https://conductscience.org/library/papers/441578 | PubMed |
| 4 | 7350435 | Oral hydralazine therapy for primary pulmonary hypertension. | N Engl J Med | 1980 | https://conductscience.org/library/papers/7350435 | PubMed |
| 5 | 7350437 | Diazoxide in primary pulmonary hypertension. | N Engl J Med | 1980 | https://conductscience.org/library/papers/7350437 | PubMed |
| 6 | 6154242 | Vasodilator therapy for pulmonary hypertension. | N Engl J Med | 1980 | https://conductscience.org/library/papers/6154242 | PubMed |
| 7 | 7295436 | Hazards of diazoxide in pulmonary hypertension. | Br Heart J | 1981 | https://conductscience.org/library/papers/7295436 | PubMed |
| 8 | 7060242 | Unexplained pulmonary hypertension. | Circulation | 1982 | https://conductscience.org/library/papers/7060242 | PubMed |
| 9 | 7070457 | Deleterious effects of hydralazine in patients with pulmonary hypertension. | N Engl J Med | 1982 | https://conductscience.org/library/papers/7070457 | PubMed |
| 10 | 6804111 | Oxygen utilization and ventilation during exercise in patients with chronic cardiac failure. | Circulation | 1982 | https://conductscience.org/library/papers/6804111 | PubMed |
| 11 | 7046988 | Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension. | Circulation | 1982 | https://conductscience.org/library/papers/7046988 | PubMed |
| 12 | 7049203 | Captopril as treatment for patients with pulmonary hypertension. Problem of variability in assessing chronic drug treatment. | Br Heart J | 1982 | https://conductscience.org/library/papers/7049203 | PubMed |
| 13 | 7049212 | Side effects occurring during administration of epoprostenol (prostacyclin, PGI2), in man. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7049212 | PubMed |
| 14 | 6849224 | Reassessment of the effects of vasodilator drugs in primary pulmonary hypertension: guidelines for determining a pulmonary vasodilator response. | Am Heart J | 1983 | https://conductscience.org/library/papers/6849224 | PubMed |
| 15 | 6625374 | Treatment of primary pulmonary hypertension with nifedipine. A hemodynamic and scintigraphic evaluation. | Ann Intern Med | 1983 | https://conductscience.org/library/papers/6625374 | PubMed |
| 16 | 6652000 | Haemodynamic response to intravenous hydralazine in patients with pulmonary hypertension. | Br Heart J | 1983 | https://conductscience.org/library/papers/6652000 | PubMed |
| 17 | 6143976 | Long-term treatment of primary pulmonary hypertension with continuous intravenous epoprostenol (prostacyclin). | Lancet | 1984 | https://conductscience.org/library/papers/6143976 | PubMed |
| 18 | 6148159 | Primary pulmonary hypertension: natural history and the importance of thrombosis. | Circulation | 1984 | https://conductscience.org/library/papers/6148159 | PubMed |
| 19 | 6148512 | Rebound platelet activation during continuous epoprostenol infusion. | Lancet | 1984 | https://conductscience.org/library/papers/6148512 | PubMed |
| 20 | 6482934 | Right-sided infective endocarditis as a consequence of flow-directed pulmonary-artery catheterization. A clinicopathological study of 55 autopsied patients. | N Engl J Med | 1984 | https://conductscience.org/library/papers/6482934 | PubMed |
Cited by30
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 159 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40013009 | How a Most Unlikely Drug Changed the Outcome of Pulmonary Arterial Hypertension. | Pulm Circ | 2025 | https://conductscience.org/library/papers/40013009 | PubMed |
| 39906119 | Pulmonary Hypertension: A Personal Journey. | Pulm Circ | 2025 | https://conductscience.org/library/papers/39906119 | PubMed |
| 35859133 | Assessment of disease outcome measures in systemic sclerosis. | Nat Rev Rheumatol | 2022 | https://conductscience.org/library/papers/35859133 | PubMed |
| 35795488 | Epoprostenol-associated ascites in pulmonary arterial hypertension. | Pulm Circ | 2022 | https://conductscience.org/library/papers/35795488 | PubMed |
| 34776414 | A narrative review on adverse effects of dasatinib with a focus on pharmacotherapy of dasatinib-induced pulmonary toxicities. | Blood Res | 2021 | https://conductscience.org/library/papers/34776414 | PubMed |
| 28126964 | Prostacyclin-analog therapy in sickle cell pulmonary hypertension. | Haematologica | 2017 | https://conductscience.org/library/papers/28126964 | PubMed |
| 25848300 | Prostanoid therapies in the management of pulmonary arterial hypertension. | Ther Clin Risk Manag | 2015 | https://conductscience.org/library/papers/25848300 | PubMed |
| 24937180 | Pharmacologic therapy for pulmonary arterial hypertension in adults: CHEST guideline and expert panel report. | Chest | 2014 | https://conductscience.org/library/papers/24937180 | PubMed |
| 24140503 | Elevated prostacyclin biosynthesis in mice impacts memory and anxiety-like behavior. | Behav Brain Res | 2014 | https://conductscience.org/library/papers/24140503 | PubMed |
| 21941650 | Diagnosis and management of pulmonary arterial hypertension. | Pulm Med | 2011 | https://conductscience.org/library/papers/21941650 | PubMed |
| 15846646 | Prostacyclin for pulmonary hypertension in adults. | Cochrane Database Syst Rev | 2005 | https://conductscience.org/library/papers/15846646 | PubMed |
| 12800450 | [Consensus recommendations of the Pulmonary Arterial Hypertension Study Group of the Austrian Society of Lung Diseases and Tuberculosis]. | Wien Klin Wochenschr | 2003 | https://conductscience.org/library/papers/12800450 | PubMed |
| 11293650 | Drug treatment of scleroderma. | Drugs | 2001 | https://conductscience.org/library/papers/11293650 | PubMed |
| 10451689 | Pulmonary hypertension: its assessment and treatment. | Thorax | 1999 | https://conductscience.org/library/papers/10451689 | PubMed |
| 9813561 | Long-term intravenous prostaglandin (epoprostenol or iloprost) for treatment of severe pulmonary hypertension. | Heart | 1998 | https://conductscience.org/library/papers/9813561 | PubMed |
| 9711442 | The future potential of eicosanoids and their inhibitors in paediatric practice. | Drugs | 1998 | https://conductscience.org/library/papers/9711442 | PubMed |
| 9538312 | Treatment of pulmonary hypertension with the continuous infusion of a prostacyclin analogue, iloprost. | Heart | 1998 | https://conductscience.org/library/papers/9538312 | PubMed |
| 9155601 | Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin. | Heart | 1997 | https://conductscience.org/library/papers/9155601 | PubMed |
| 8708174 | The use of inhaled aerosolized prostacyclin (IAP) in the treatment of pulmonary hypertension secondary to pulmonary embolism. | Intensive Care Med | 1996 | https://conductscience.org/library/papers/8708174 | PubMed |
| 8217447 | Prostacyclin (epoprostenol) and heart-lung transplantation as treatments for severe pulmonary hypertension. | Br Heart J | 1993 | https://conductscience.org/library/papers/8217447 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3552006
GET https://conductscience.org/api/papers/v1/3552006/references?page=2